T1D Clinical Trial Search Engine Now Available In Spanish


Beyond Type 1 is excited to announce that we have collaborated with Antidote Technologies and JDRF to provide a Spanish language version of the clinical trial search tool. As the first ever type 1 diabetes (T1D) clinical trial search to be offered in Spanish, we are thrilled to be on the forefront of this groundbreaking development.

Who participates in clinical trials?

Despite the fact that individuals of a Hispanic background make up around 18% of the U.S. population, less than 8% of all clinical trial participants identify as Hispanic

Additionally, new research has found that Hispanic American youth are diagnosed with T1D more often than other demographics. Developing new and better T1D treatments is vital, but that can only happen when the people who participate in clinical trials are reflective of the real-world demographic of those living with diabetes. 

Because the United States is the world’s second-largest Spanish-speaking country, we are confident that this new development will improve diversity, equity and inclusion in type 1 diabetes clinical trials. Although the search tool is now in Spanish, the clinical trials may or may not be held in Spanish.

How to find a clinical trial

To use the new tool in either English or Spanish, you can visit our research trials page today! Choose between an English or Spanish version and answer a few health-related questions to learn more about T1D clinical trial opportunities in your preferred language. 

We are so excited to be able to bring this technology to our community and expand research participation opportunities to Spanish-speaking individuals living with T1D every day. 

Be a part of finding a cure for T1D by enrolling in a clinical trial near you. Learn more about the importance of clinical trials here.

This content mentions JDRF, an active partner of Beyond Type 1.
News coverage by the Beyond Type 1 team is operated independently from any content partnerships. Beyond Type 1 maintains full editorial control of all content published on our platforms.

WRITTEN BY BT1 Editorial Team, POSTED 09/07/23, UPDATED 09/07/23

This piece was authored collaboratively by the Beyond Type 1 Editorial Team.